Zai Lab Ltd (ZLAB) plummeted 5.48% in the pre-market trading session on Monday, following a downgrade by BofA Securities analysts.
BofA Securities cut its rating on Zai Lab to Neutral from Buy, citing concerns over the growth slowdown of the company's core products. The bank also raised its price target on the stock to $36.10 from $29, which is still significantly below the current trading levels.
The downgrade from a major investment bank like BofA likely triggered a wave of selling pressure on Zai Lab shares. Analyst downgrades and lowered price targets can negatively impact investor sentiment and lead to stock price declines, especially for growth companies like Zai Lab.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。